CRISPR Therapeutics AG (CRSP)
50.16
+0.06
(+0.12%)
USD |
NASDAQ |
Oct 14, 10:12
CRISPR Therapeutics EPS Diluted (TTM) : -4.761 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.761 |
| March 31, 2026 | -6.212 |
| December 31, 2025 | -6.514 |
| September 30, 2025 | -5.580 |
| June 30, 2025 | -5.423 |
| March 31, 2025 | -4.516 |
| December 31, 2024 | -4.359 |
| September 30, 2024 | -2.824 |
| June 30, 2024 | -3.228 |
| March 31, 2024 | -2.722 |
| December 31, 2023 | -1.971 |
| September 30, 2023 | -4.481 |
| June 30, 2023 | -5.306 |
| March 31, 2023 | -6.721 |
| December 31, 2022 | -8.371 |
| September 30, 2022 | -8.802 |
| June 30, 2022 | -8.231 |
| March 31, 2022 | 3.603 |
| December 31, 2021 | 4.419 |
| September 30, 2021 | 4.760 |
| June 30, 2021 | 5.109 |
| March 31, 2021 | -5.625 |
| Date | Value |
|---|---|
| December 31, 2020 | -5.262 |
| September 30, 2020 | -3.254 |
| June 30, 2020 | 0.4674 |
| March 31, 2020 | 0.7547 |
| December 31, 2019 | 0.9714 |
| September 30, 2019 | -0.4564 |
| June 30, 2019 | -3.930 |
| March 31, 2019 | -3.739 |
| December 31, 2018 | -3.427 |
| September 30, 2018 | -2.503 |
| June 30, 2018 | -2.053 |
| March 31, 2018 | -1.793 |
| December 31, 2017 | -1.716 |
| September 30, 2017 | -1.290 |
| June 30, 2017 | -3.440 |
| March 31, 2017 | -3.315 |
| December 31, 2016 | -2.990 |
| September 30, 2016 | -3.513 |
| June 30, 2016 | -0.825 |
| March 31, 2016 | -0.3891 |
| June 30, 2015 | -0.1747 |
| March 31, 2015 | -0.0822 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 17.19 |
| Basilea Pharmaceutica AG | 4.920 |
| Santhera Pharmaceuticals Holding AG | -2.881 |
| BeOne Medicines Ltd. | 5.690 |
| AC Immune SA | -0.556 |